Richard B. Newman
Chief Executive Officer at D&R Products Co., Inc.
Network origin in Richard B. Newman first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
21
| Extinct | Pharmaceuticals: Major | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard B. Newman via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CATERPILLAR INC. | Trucks/Construction/Farm Machinery | Corporate Officer/Principal | |
| FORD MOTOR COMPANY | Motor Vehicles | Corporate Officer/Principal | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DURECT CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Director/Board Member | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Bullet Biotechnology, Inc.
 Bullet Biotechnology, Inc. BiotechnologyHealth Technology Bullet Biotechnology, Inc. develops active immunotherapies to stimulate a person’s own immune system to overcome diseases. Its technology educates the immune system to targeting specific cells that are causing disease. The firm's pipeline includes therapeutic vaccines for cancer, multi-specific antibody capsid products, therapeutic vaccines for autoimmune diseases, and other vaccines. The company was founded by Diego Fonstad, James R. Swartz, Willie Quinn and Thomas Theriault in September 2011 and is headquartered in Redwood City, CA. | Biotechnology | Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
| Kansas State University | College/University | Undergraduate Degree | |
| Santa Clara University | College/University | Director/Board Member | |
| University of Arizona | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Graduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Ilypsa, Inc.
 Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA. | Biotechnology | Chief Executive Officer | |
| Christopher & Dana Reeve Foundation | Investment Trusts/Mutual Funds | Chairman | |
| Syntex Laboratories, Inc. | Corporate Officer/Principal | ||
| RELYPSA INC | Pharmaceuticals: Major | Founder | |
Xenerex Biosciences
 Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Xenerex Biosciences engages in developing and commercializing human antibody products to target antigens. The company was founded by John David Hansen and Wolfgang W. Scholz and is headquartered in Aliso Viejo, CA. | Miscellaneous Commercial Services | Founder Founder | |
| ALZA Pharmaceuticals | Corporate Officer/Principal | ||
| Altair Capital Associates LLC | Founder | ||
Craig Hospital
 Craig Hospital Hospital/Nursing ManagementHealth Services Craig Hospital is a center for specialty rehabilitation and research for people with spinal cord injury and traumatic brain injury. The firm provides a system of inpatient and outpatient medical care, rehabilitation, neurosurgical rehabilitative care and long-term follow up services. The company was founded in 1907 and is headquartered in Denver, CO. | Hospital/Nursing Management | Director/Board Member | |
Hanson Cold Storage Co.
 Hanson Cold Storage Co. Miscellaneous Commercial ServicesCommercial Services Part of Lineage Logistics Holdings LLC, Hanson Cold Storage Co. provides refrigerated warehousing and storage services. The company is based in St. Joseph, MI. Hanson Cold Storage was acquired by Lineage Logistics LLC on August 04, 2021. | Miscellaneous Commercial Services | Director/Board Member | |
| California State Polytechnic University (Pomona) | College/University | Masters Business Admin | |
| Financial Executives International of San Diego Chapter | President | ||
| MABVAX THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director of Finance/CFO Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
First Cornerstone Group LLC
 First Cornerstone Group LLC Miscellaneous Commercial ServicesCommercial Services First Cornerstone Group LLC operates as a real estate investment education and marketing company. The company was founded by Lance Edwards in 2004 and is headquartered in Houston, TX. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | Financial Conglomerates | Director/Board Member | |
| Sofinnova Ventures | Corporate Officer/Principal | ||
Cessation Therapeutics, LLC
 Cessation Therapeutics, LLC Pharmaceuticals: MajorHealth Technology Cessation Therapeutics, LLC is a clinical-stage pharmaceutical company that develops immunobiologics to prevent and protect against overdose. The company is based in San Jose, CA. The company's monoclonal antibodies are designed to target fentanyl and future synthetic opioids and other substances. The company has the potential to treat a range of substance use disorders and improve the lives of patients and families affected by the addiction crisis. Cessation was founded in 2018 by Mark Pearson and John D. Harkey, Jr., experienced, successful long-term biotech investors. The CEO is Mark E. Pearson. | Pharmaceuticals: Major | Director/Board Member | |
Aculys Pharma LLC
 Aculys Pharma LLC Pharmaceuticals: MajorHealth Technology Aculys Pharma LLC is a Japanese biopharmaceutical company that focuses on developing and commercializing innovations in the fields of neurology and psychiatry. The company is based in Japan and was established in January 2021. The company's philosophy is to act as a catalyst to access innovative medical care in the field of neuropsychiatry. Aculys Pharma develops and commercializes novel pharmaceuticals and provides innovations for better medical care to patients, their families, healthcare professionals, and society. | Pharmaceuticals: Major | Director/Board Member | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Founder |
Statistics
International
| United States | 49 |
| Japan | 3 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 5 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 105 |
| Corporate Officer/Principal | 54 |
| Independent Dir/Board Member | 43 |
| Director of Finance/CFO | 21 |
| Founder | 15 |
Most connected contacts
| Insiders | |
|---|---|
| Jay Shepard | 30 |
| Mary Gray | 27 |
| Paul Maier | 25 |
| Stefan Ryser | 16 |
| Cynthia Butitta | 16 |
| Gregory P. Hanson | 15 |
| Robert W. Frick | 14 |
| Kenneth M. Cohen | 12 |
| Jeffrey V. Ravetch | 11 |
| Wolfgang W. Scholz | 8 |
| Philip O. Livingston | 8 |
| Edward W. Cantrall | 7 |
| William Phillip Kaplan | 7 |
| John David Hansen | 7 |
| Le-Van Nguyen | 6 |
- Stock Market
- Insiders
- Richard B. Newman
- Company connections
